Clinical Trial Update: A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005) [Phase 2]

View source ↗

Summary

Phase 2 trial update for MK-0893 assessing safety, tolerability, and glucose-lowering efficacy in type 2 diabetes mellitus; study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0893

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-03-18